Similar Papers

Paper Title
Journal
Date
Author
Abstract P5-09-04: Regulation of mTOR signaling pathway by ING4 in breast cancer: A new target in cancer therapy
Aymen Shatnawi ... Travis Salisbury
Cancer Research | VOL. 82
Aymen Shatnawi, et. al.Aymen Shatnawi ... Travis Salisbury
15 Feb 2022
Abstract 4362: Identification and isolation of host factors in response to therapy: an approach to identify new targets for cancer therapy
Svetlana Gingis-Velitski ... Ella Fremder
Cancer Research | VOL. 72
Svetlana Gingis-Velitski, et. al.Svetlana Gingis-Velitski ... Ella Fremder
15 Apr 2012
Tumor endothelial markers: new targets for cancer therapy.
Akash Nanda ... Brad St Croix
Current Opinion in Oncology | VOL. 16
Akash Nanda, et. al.Akash Nanda ... Brad St Croix
01 Jan 2004
PTK7 Is Involved in the Chemotherapy Resistance of T-Cell Acute Lymphoblastic Leukemia through Interaction with FADD-Death Domain
Hideki Goto ... Shu-Ichi Matsuzawa
Blood | VOL. 126
Hideki Goto, et. al.Hideki Goto ... Shu-Ichi Matsuzawa
03 Dec 2015
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Cancer-Specific Utility Instrument for Health Economic Evaluations: A Synopsis of the EORTC QLU-C10D User Manual and Current Validity Evidence
Simone Seyringer ... Eva M Gamper
European Journal of Cancer | VOL. -
Simone Seyringer, et. al.Simone Seyringer ... Eva M Gamper
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
Neoadjuvant or perioperative immunotherapy for resectable melanoma: the need for biomarkers
Eva Ellebæk ... Inge Marie Svane
European Journal of Cancer | VOL. -
Eva Ellebæk, et. al.Eva Ellebæk ... Inge Marie Svane
01 Jan 2025
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
Kwee Yong ... Binod Dhakal
European Journal of Cancer | VOL. 215
Kwee Yong, et. al.Kwee Yong ... Binod Dhakal
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.